Healthcare & Life Sciences

One Chain

seed
seed
Stage
1
Investors

About

One Chain is a clinical stage company developing CAR-T therapies for the treatment of oncological diseases, originating as a spin-off from the Josep Carreras Leukemia Research Institute and ICREA.

Explore One Chain's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.